Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Therapeutically active NPY analog reported by academic source

Dec. 9, 1996

Oncogene Science issued patent on gene transcription

Dec. 6, 1996

Anti-E-selectin antisense compound from Isis inhibits mRNA splicing

Dec. 6, 1996

Cytel announces plans for Cylexin at investors conference

Dec. 5, 1996

New endothelin receptor modulators reported by Texas Biotechnology

Dec. 4, 1996

Once-daily antihypertensive combination cleared for marketing in Canada

Dec. 3, 1996

New hope for heart failure patients

Dec. 3, 1996

Therapeutically active NPY analogues reported by Salk Institute

Dec. 2, 1996

Takeda discloses natural ET receptor antagonist

Nov. 29, 1996

NEP inhibitors claimed by Santen

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...